Everpure, Inc. ⋅ 10-Q ⋅ 6/5 NetApp, Inc. ⋅ 10-K ⋅ 6/5 VEEVA SYSTEMS INC ⋅ 10-Q ⋅ 6/5 Planet Labs PBC ⋅ 10-Q ⋅ 6/5 Rubrik, Inc. ⋅ 10-Q ⋅ 6/5 BEST BUY CO INC ⋅ 10-Q ⋅ 6/5 COOPER COMPANIES, INC. ⋅ 10-Q ⋅ 6/5 DOCUSIGN, INC. ⋅ 10-Q ⋅ 6/5 DILLARD'S, INC. ⋅ 10-Q ⋅ 6/5 ServiceTitan, Inc. ⋅ 10-Q ⋅ 6/5

Everpure, Inc. ⋅ 10-Q ⋅ 6/5 NetApp, Inc. ⋅ 10-K ⋅ 6/5 VEEVA SYSTEMS INC ⋅ 10-Q ⋅ 6/5 Planet Labs PBC ⋅ 10-Q ⋅ 6/5 Rubrik, Inc. ⋅ 10-Q ⋅ 6/5 BEST BUY CO INC ⋅ 10-Q ⋅ 6/5 COOPER COMPANIES, INC. ⋅ 10-Q ⋅ 6/5 DOCUSIGN, INC. ⋅ 10-Q ⋅ 6/5 DILLARD'S, INC. ⋅ 10-Q ⋅ 6/5 ServiceTitan, Inc. ⋅ 10-Q ⋅ 6/5

AbbVie Inc.

Pharmaceutical Preparations | SIC: 2834
Phone: (847) 932-7900

CIK: 0001551152
EIN: 320375147
State Location: IL
State of Inc.: DE

NYSE:ABBV

Form: SCHEDULE 13G/A

Filing Date: 26 Mar 2026
Report Date:
Accepted: 26 Mar 2026 01:06 p.m.
Accession Number: 0000102909-26-000503

Act: 34
File Number: 005-87819
Film Number: 26797269

Documents

Primary Document

Accepted: 26 Mar 2026 01:06 p.m.

0000102909-26-000503-index-headers.html

Last Modified: 26 Mar 2026 01:06 p.m.

0000102909-26-000503-index.html

Last Modified: 26 Mar 2026 01:06 p.m.

0000102909-26-000503.txt

Last Modified: 26 Mar 2026 01:06 p.m.

primary_doc.xml

Last Modified: 26 Mar 2026 01:06 p.m.